The effect of neutrophil lymphocyte ratio and other biochemical parameters on mortality in cancer patients admitted to the emergency department
Intercontinental Journal of Emergency Medicine · 2023
DOI: 10.51271/icjem-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intercontinental Journal of Emergency Medicine, 2023. Verfasst von Nahide Gizem Okay und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aims
To investigate the effectiveness of the neutrophil/lymphocyte ratio and other biochemical parameters in predicting mortality in oncology patients with cancer admitted to the emergency department.
Methods
This was a retrospective, observational, single-center study. The study period included a two-year period from January 2014 to December 2015. Demographic data, cancer history and blood tests, emergency department diagnoses, blood parameters evaluated in the emergency department, discharge, and mortality status of the patients were recorded in the data form. The APACHE 2 and SOFA scores of all patients were also calculated. Patients whose data could not be reached were excluded from the study. p
Zitieren
APA
Okay, N. G., Kibici, Ö., & Erdoğan, M. Ö. (2023). The effect of neutrophil lymphocyte ratio and other biochemical parameters on mortality in cancer patients admitted to the emergency department. Intercontinental Journal of Emergency Medicine. https://doi.org/10.51271/icjem-0018
Vancouver
Okay NG, Kibici Ö, Erdoğan MÖ. The effect of neutrophil lymphocyte ratio and other biochemical parameters on mortality in cancer patients admitted to the emergency department. Intercontinental Journal of Emergency Medicine. 2023. doi:10.51271/icjem-0018
BibTeX
@article{Okay2023,
author = {Okay, Nahide Gizem and Kibici, Özge and Erdoğan, Mehmet Özgür},
title = {The effect of neutrophil lymphocyte ratio and other biochemical parameters on mortality in cancer patients admitted to the emergency department},
journal = {Intercontinental Journal of Emergency Medicine},
year = {2023},
doi = {10.51271/icjem-0018}
}
EUVIMED